[email protected]
Bob Steele
Professor; Editor, “The Surgeon”; Co-Founder & Co-Director, Scottish Cancer Prevention Network
Professor Bob Steele obtained his initial surgical and academic training in Edinburgh, Hong Kong and Aberdeen and was appointed as Senior Lecturer in Surgery at the University of Nottingham in 1990. He was then appointed Professor of Surgical Oncology at the University of Dundee in 1996 and as Professor of Surgery and Head of Academic Surgery in 2003.
Steele’s main interests are the treatment of and screening for colorectal cancer. Having led the UK demonstration pilot that was used to inform the decision to introduce national screening programs throughout the United Kingdom, he is at present the Clinical Director of the Scottish Colorectal Cancer Screening Programme, and has published extensively in this area.
He has chaired several NHS QIS and HIS groups related to colorectal cancer and colorectal cancer screening and he chaired the SIGN group that developed the latest set of colorectal cancer guidelines. He is a past member of Council of the Royal College of Surgeons of Edinburgh, past Chair of the Health Improvement, Protection and Services (HIPS) Research Committee of the Scottish Government’s Chief Scientist’s Office, and past President of the Association of Coloproctology of Great Britain and Ireland.
Steele is currently Editor of “The Surgeon”, co-founder and co-director of the Scottish Cancer Prevention Network and Chair of the Board of Directors of the Scottish Cancer Foundation. In 2016, he was appointed as Independent Chair of the UK National Screening Committee. In 2017 he was awarded an Honorary Membership of the Faculty of Public Health and was elected to the Fellowship of the Royal Society of Edinburgh. In 2018 he was elected to Fellowship of the Academy of Medical Sciences and was awarded a CBE in the Queen’s Birthday Honours List.
Videos
News
Related Speakers View all
Dr. Daniel J. Spakowicz
Research Assistant Professor in the Division of Medi...
|
|
Nikhil Wagle
Director, Count Me In, Broad Institute
|
|
Dr. Elizabeth Jaffee
International Leader in Immune Based Therapies for P...
|
|
Hasini Jayatilaka
Postdoctoral Researcher at Stanford University
|
|
Inmaculada Hernandez
Pharmaceutical Health Services Researcher & Accessib...
|
|
Lisa Cooper
Director at Johns Hopkins Center for Health Equity a...
|
|
Laurie H. Glimcher
President & CEO of Dana-Farber Cancer Institute; Can...
|
|
Elias Zerhouni
President & Vice Chairman at OPKO Health, Inc.; Pro...
|
|
Rick Berke
Co-Founder & Executive Editor at STAT
|
|
Stephanie Lheureux
Clinician Investigator & Medical Oncologist at Princ...
|
|
Kai W. Wucherpfennig, MD, PhD
Professor, Microbiology and Immunobiology, Harvard M...
|
|
Thomas J Bartosh, PhD
Assistant Professor, Texas A&M University Health Sci...
|
|
Paul Workman
Chief Executive & President, The Institute of Cancer...
|
|
Dr. Jarushka Naidoo
Assistant Professor of Oncology at the Sidney Kimmel...
|
|
Dr. Zoltan Lohinai
Pulmonary Oncologist & Researcher at the National Ko...
|
|
Dr. Kellie Smith
Assistant Professor of Oncology; Recipient of Lung C...
|
|
Haiying Cheng, MD, PhD
Physician-Scientist at Albert Einstein College; Reci...
|
|
Tom Mikkelsen
President, Ontario Brain Institute
|
|
Garabet Yeretssian
Director of the Helmsley Charitable Trust’s Crohn’s ...
|
|
Derek B. Lowe
Director in Chemical Biology Therapeutics; Author; R...
|